Stock market correction sends biopharma back to the start of 2021
Covid-19 vaccine developers stand out as global drug stocks tread water in the first quarter.
Blood clot fears spread to J&J’s Covid-19 vaccine
The US pauses use of JNJ-78436735 after six cases of cerebral venous sinus thrombosis.
Astra counts the cost of its Covid-19 vaccine
The link between Astrazeneca’s vaccine and blood clots strengthens, but forecasts show that it was never expected to generate huge sales.
Astra’s Covid-19 vaccine: much ado about nothing?
With results of the full primary analysis now out the spotlight falls on a further 14 as yet unadjudicated Covid-19 cases.
Astrazeneca silences its Covid-19 vaccine doubters
AZD1222 could be rehabilitated by US pivotal trial data showing efficacy of 79%, with no worries about blood clots.
Astra’s Covid-19 vaccine woes deepen
Denmark’s suspension of AZD1222 following blood clots heaps even more pressure on Astra’s US study.
Vaccine developers move to stay ahead of Covid-19 variants
Though current vaccines show efficacy, work on next-generation iterations against the South Africa variant is under way.
